August 25, 2025 · Form 4 insider transaction
Mottola Frank sold 14,000 shares of Supernus Pharmaceuticals, Inc. at $44.51 per share, a transaction worth $623.1K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
The Reporting Person exercised the options indicated herein and sold the underlying shares prior to the expiration of such options on March 1, 2026.